Anthony E Dear Selected Research

oxamflatin

5/2008	Characterisation of the novel apoptotic and therapeutic activities of the histone deacetylase inhibitor romidepsin.
7/2004	Novel inhibitors of urokinase-type plasminogen activator and matrix metalloproteinase expression in metastatic cancer cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anthony E Dear Research Topics

Disease

7	Atherosclerosis 01/2018 - 03/2008
5	Abdominal Aortic Aneurysm 06/2022 - 03/2007
5	Neoplasms (Cancer) 02/2019 - 08/2003
5	Necrosis 01/2018 - 01/2008
4	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2008
3	Hyperplasia 01/2021 - 12/2019
3	Cardiovascular Diseases (Cardiovascular Disease) 10/2013 - 09/2010
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2019 - 09/2016
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2019 - 09/2016
2	Thrombosis (Thrombus) 10/2011 - 04/2005
2	Inflammation (Inflammations) 09/2010 - 07/2004
1	Neointima 12/2019
1	Obesity 01/2016
1	Hypertension (High Blood Pressure) 01/2016
1	Fibrosis (Cirrhosis) 01/2016
1	Ischemic Stroke 10/2013
1	Weight Gain 07/2013
1	Vascular Diseases (Vascular Disease) 07/2013
1	Atherosclerotic Plaque (Atheroma) 07/2013
1	Diabetic Angiopathies (Diabetic Angiopathy) 04/2011
1	Breast Neoplasms (Breast Cancer) 07/2009
1	B-Cell Lymphoma (Lymphoma, B Cell) 05/2008
1	Lymphoma (Lymphomas) 05/2008
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 05/2008
1	Hematologic Neoplasms (Hematological Malignancy) 05/2008
1	Drug-Related Side Effects and Adverse Reactions 07/2007
1	Aortic Aneurysm (Aneurysm, Aortic) 03/2007
1	Avitaminosis (Vitamin Deficiency) 09/2002
1	Peripheral Arterial Disease 09/2002

Drug/Important Bio-Agent (IBA)

7	Histone Deacetylase InhibitorsIBA 01/2020 - 08/2003
6	Liraglutide FDA Link 01/2022 - 04/2009
6	Plasminogen InactivatorsIBA 01/2018 - 07/2004
4	Biomarkers (Surrogate Marker)IBA 06/2022 - 06/2015
4	Pharmaceutical PreparationsIBA 01/2021 - 08/2003
4	Glucagon-Like Peptide-1 ReceptorIBA 01/2016 - 04/2011
3	ApolipoproteinsIBA 01/2018 - 01/2008
3	Angiotensin IIIBA 01/2016 - 01/2008
3	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2013 - 01/2008
3	Messenger RNA (mRNA)IBA 03/2013 - 07/2004
3	Proteins (Proteins, Gene)FDA Link 03/2013 - 01/2008
3	Matrix Metalloproteinases (MMPs)IBA 03/2008 - 07/2004
3	EnzymesIBA 01/2008 - 09/2002
2	Hydroxamic Acids (Hydroxamic Acid)IBA 01/2020 - 07/2004
2	Orphan Nuclear ReceptorsIBA 02/2019 - 01/2011
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2018 - 03/2013
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2018 - 03/2013
2	Telmisartan (Micardis)FDA Link 01/2016 - 06/2015
2	Dipeptidyl-Peptidase IV InhibitorsIBA 03/2013 - 01/2008
2	oxamflatinIBA 05/2008 - 07/2004
2	Biological ProductsIBA 05/2008 - 07/2004
2	PlasminogenIBA 01/2008 - 07/2004
2	Warfarin (Coumadin)FDA LinkGeneric 07/2007 - 04/2005
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	4-Aminobenzoic Acid (4 Aminobenzoic Acid)IBA 12/2019
1	Azacitidine (5 Azacytidine)FDA Link 02/2019
1	B7-H1 AntigenIBA 02/2019
1	Programmed Cell Death 1 ReceptorIBA 02/2019
1	dapagliflozinIBA 01/2018
1	Sodium-Glucose Transport ProteinsIBA 01/2018
1	MicroRNAs (MicroRNA)IBA 09/2016
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 09/2016
1	RNA (Ribonucleic Acid)IBA 09/2016
1	Enhancer of Zeste Homolog 2 ProteinIBA 09/2016
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2016
1	Angiotensin Receptor AntagonistsIBA 06/2015
1	IncretinsIBA 10/2013
1	Endothelin-1 (Endothelin 1)IBA 10/2013
1	Exenatide (Byetta)FDA Link 10/2013
1	NF-kappa B (NF-kB)IBA 10/2013
1	Apolipoproteins E (ApoE)IBA 07/2013
1	Sitagliptin Phosphate (Januvia)FDA Link 03/2013
1	Cytochrome P-450 CYP2C19IBA 10/2011
1	Clopidogrel (Plavix)FDA Link 10/2011
1	ThiazolidinedionesIBA 01/2011
1	DNA (Deoxyribonucleic Acid)IBA 09/2010
1	Histones (Histone)IBA 09/2010
1	Estrogen ReceptorsIBA 07/2009
1	Tamoxifen FDA LinkGeneric 07/2009
1	Vorinostat FDA Link 05/2008
1	romidepsin (FK228)FDA Link 05/2008
1	CollagenIBA 03/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2008
1	Plasminogen Activator Inhibitor 1IBA 01/2008
1	OsteopontinIBA 03/2007
1	matrigelIBA 07/2004
1	metacept-1IBA 07/2004
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 07/2004
1	HomocysteineIBA 09/2002
1	Vitamin B 6IBA 09/2002
1	Folic Acid (Vitamin M)FDA LinkGeneric 09/2002

Therapy/Procedure

3	Therapeutics 02/2019 - 10/2011
1	Catheters 01/2021
1	Stents 10/2011
1	Drug Therapy (Chemotherapy) 08/2003